Cardiovascular Systems Inc
CSIIDelisted Apr 27, 2023- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001180145
Cardiovascular Systems Inc was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 27, 2023; 150 institutions reported holding it in 13F filings for Q1 2023, worth $766.5M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cardiovascular Systems Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cardiovascular Systems Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ward Scott R. | Chairman and CEO | 0 | Apr 27, 2023 | 0 |
| Lawlor Augustine | Director | 0Indirect | Apr 27, 2023 | 0 |
| Aronson Martha Goldberg | Director | 0 | Apr 27, 2023 | 0 |
| Cohn William E. | Director | 0 | Apr 27, 2023 | 0 |
| Rosenstein Alexander | General Counsel & Corp. Sec. | 0 | Apr 27, 2023 | 0 |
| Sedo Sandra | Chief Compliance Officer | 0 | Apr 27, 2023 | 0 |
| Points Jeffrey S. | Chief Financial Officer | 0 | Apr 27, 2023 | 0 |
| Paulsen Erik | Director | 0 | Apr 27, 2023 | 0 |
| Stenbeck Stephen | Director | 0 | Apr 27, 2023 | 0 |
| Rempe Stephen J. | Chief Human Resources Officer | 0 | Apr 27, 2023 | 0 |
| Womack Kelvin K. | Director | – | Apr 27, 2023 | 0 |
| Hastings John M. | VP Manufacturing & Operations | 53,652 | Aug 16, 2022 | 0 |
| Jain Sachin H. | Director | 1,447 | Aug 9, 2022 | 0 |
| Robb Rhonda J. | Chief Operating Officer | 169,581 | Feb 9, 2022 | 0 |
| Egeland Ryan | Chief Medical Officer | 76,180 | Feb 9, 2022 | 0 |
| Whitescarver David | VP of Corp. Dev. and IP | 63,264 | Feb 9, 2022 | 0 |
| Brown Edward M | Director | – | Aug 11, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2022 (view filing) | May 20 | 3 days | Points Jeffrey S.Chief Financial Officer | PPurchase | +3.00K | $14.50 | +$43.5K | +2.8%109.3K after | |
| May 23, 2022 (view filing) | May 20 | 3 days | Ward Scott R.Chairman and CEO | PPurchase | +3.00K | $14.49 | +$43.5K | +0.5%580.7K after | |
| Feb 24, 2022 (view filing) | Feb 23 | 1 day | Paulsen ErikDirector | PPurchase | +500 | $19.05 | +$9.53K | +250.0%700 after | |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Aronson Martha GoldbergDirector | PPurchase | +2.50K | $18.43 | +$46.1K | +33.3%10.0K after | |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Robb Rhonda J.Chief Operating Officer | PPurchase | +1.57K | $18.72 | +$29.3K | +1.0%164.1K after | |
| Feb 9, 2022 (view filing) | Feb 8 | 1 day | Points Jeffrey S.Chief Financial Officer | PPurchase | +2.00K | $18.20 | +$36.4K | +2.0%100.8K after | |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Ward Scott R.Chairman and CEO | PPurchase | +2.50K | $18.52 | +$46.3K | +0.4%572.2K after |